Mycoplasma bovis immunity-related protein P22, nucleotide sequence for coding same and application thereof
A nucleotide sequence, Mycoplasma bovis technology, applied in the field of biomedicine, can solve the problems of less research on the immunogenicity and immune protection characteristics of Mycoplasma bovis components, and the lack of obvious immunogenicity of VSP protein
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0033] 1 Materials and methods
[0034] 1.1 Strain and serum
[0035] M.bovis Hubei-1 isolate (XIN Jiu-qing 1* , LI Yuan 1 , GUO Dan 1 et al., First isolation of Mycoplasma bovis from calf lung with pneumoniae in China. Chinese Journal of Preventive Veterinary Medicine: 2008-09) was isolated from disease materials submitted by our research group from Hubei Province. After gene sequence detection and biochemical tests, it was identified as Mycoplasma bovis. Sera Nos. 1 and 2 used in the ELISA test came from bovine serum that was naturally infected and finally confirmed to be Mycoplasma bovis by pathogen isolation; blood No. 3 and No. 4 were healthy bovine serum produced by Hangzhou Sijiqing Bioengineering Co., Ltd. and used for cell culture. Serum Nos. 5 to 7 are hyperimmune serum obtained from challenged healthy cattle with Mycoplasma bovis isolate Hubei-1; serum No. 8 is CBPP standard positive serum from CBPP International Reference Laboratory.
[0036] 1.2 Main reagent...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com